MERUS N.V.
Share · NL0011606264 · MRUS · A2AKFX (XNMS)
55,05 USD
11.06.2025 20:00
Current Prices from MERUS N.V.
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
MRUS
|
USD
|
11.06.2025 20:00
|
55,05 USD
| 56,45 USD
-2,48 %
|
Performance
Heute | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -1,71 % | 34,60 % | 15,70 % | 27,64 % | -3,61 % | 258,63 % |
Firmenprofil zu MERUS N.V. Aktie
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1. The company is also developing MCLA-158, which is in a phase I clinical trial for the treatment of solid tumors; MCLA-145, which is in phase 1 clinical trials for the treatment of solid tumors; MCLA-129, which is in phase 1/2 clinical trials for the treatment of patients with advanced non-small cell lung cancer and other solid tumors; and ONO-4685 that is Phase 1 clinical trial to treat relapsed/refractory T cell lymphoma. In addition, it has collaboration agreement with Betta Pharmaceuticals Co. Ltd for the research and development of stage bispecific antibody candidates include MCLA-129; and collaboration with Incyte Corporation for the development of MCLA-145. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.
Unternehmensdaten
Name MERUS N.V.
Firma Merus N.V.
Symbol MRUS
Website
https://www.merus.nl
Heimatbörse
NASDAQ/NMS (GLOBAL MARKET)
WKN A2AKFX
ISIN NL0011606264
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Sven Ante Lundberg M.D.
Marktkapitalisierung 3 Mrd.
Land Niederlande
Währung USD
Mitarbeiter 0,3 T
Adresse Yalelaan 62, 3584 CM Utrecht
IPO Datum 2016-05-19
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | 2GH.F |
NASDAQ | MRUS |
Weitere Aktien
Investoren die MERUS N.V. die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.